Munn; David H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Munn; David H..The latest application filed is for "method and compositions for enhancing immunotherapeutic treatment of a cancer".

Company Profile

0.2.14

Munn; David H. - Augusta GA
MUNN; DAVID H. - AUGUST GA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method And Compositions For Enhancing Immunotherapeutic Treatment Of A Cancer App 20180008688 - Munn; David H.	2018-01-11
Methods of Promoting Immune Tolerance App 20140234373 - Mellor; Andrew L. ; et al.	2014-08-21
Antigen-presenting Cell Populations And Their Use As Reagents For Enhancing Or Reducing Immune Tolerance App 20130323832 - MUNN; DAVID H. ; et al.	2013-12-05
IMMUNOGLOBULIN Fc FRAGMENT TAGGING ACTIVATION OF ENDOGENOUS CD4 AND CD8 T CELLS AND ENHANCEMENT OF ANTITUMOR EFFECTS OF LENTIVECTOR IMMUNIZATION App 20130236456 - He; Yukai ; et al.	2013-09-12
Antigen-presenting Cell Populations And Their Use As Reagents For Enhancing Or Reducing Immune Tolerance App 20120141998 - MELLOR; ANDREW L. ; et al.	2012-06-07
Methods And Compositions To Enhance Vaccine Efficacy By Reprogramming Regulatory T Cells App 20110305713 - MUNN; David H. ; et al.	2011-12-15
Antigen-Presenting Cell Populations And Their Use As Reagents For Enhancing Or Reducing Immune Tolerance App 20100267042 - Mellor; Andrew L. ; et al.	2010-10-21
Kits to assess the risk of tumor progression Grant 7,763,251 - Mellor , et al. July 27, 2	2010-07-27
Indoleamine 2,3-dioxygenase, Pd-1/pd-l Pathways, And Ctla4 Pathways In The Activation Of Regulatory T Cells App 20100055111 - Sharma; Madhav D. ; et al.	2010-03-04
Chemokine receptor antagonists as therapeutic agents App 20090041787 - Munn; David H. ; et al.	2009-02-12
Chemokine receptor antagonists as therapeutic agents Grant 7,465,448 - Munn , et al. December 16, 2	2008-12-16
Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance App 20070048769 - Mellor; Andrew L. ; et al.	2007-03-01
Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance App 20060292618 - Mellor; Andrew L. ; et al.	2006-12-28
Chemokine receptor antagonists as therapeutic agents App 20040161425 - Munn, David H. ; et al.	2004-08-19
Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance App 20030194803 - Mellor, Andrew L. ; et al.	2003-10-16

Company Registrations

NCAGE Code	43KZ4	MUNN DAVID H
CAGE Code	43KZ4	MUNN, DAVID H
DUNS	603207338	MUNN, DAVID H

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.